Rare diseases
Investigational molecules
Locations
Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
GermanyStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
GermanyStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
GermanyStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
GermanyStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
GermanyEffect of iclepertin on the blood levels of ethinylestradiol and levonorgestrel in healthy premenopausal women
GermanyA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
GermanyEffect of carbamazepine on the blood levels of BI 1810631 after a single dose in healthy men
GermanyStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
GermanyA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
GermanyA Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
